Murillo Bellezzo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Murillo Bellezzo has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Frank Verhaegen
Maastricht University Medical Centre
11 shared publications - Brigitte Reniers
Research group NuTeC, Centre for Environmental Sciences, Hasselt University, Diepenbeek, Belgium
7 shared publications Gabriel P. Fonseca
Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
5 shared publicationsEvert J. Van Limbergen
Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
4 shared publicationsRobert Voncken
Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
4 shared publications- An-Sofie Verrijssen
Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands
3 shared publications
Latest Publications
- 17 April 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (8) , 085007
Assessing dosimetric uncertainties in Papillon+ contact x-ray brachytherapy for rectal cancer: impact of beam quality and tumour geometry
Objective. To investigate the evolution of beam quality in the Papillon+ contact x-ray therapy device and its dosimetric impact, a fast and straightforward beam quality index (QI) measurement method was proposed and validated. Additionally, the dosimetric consequences of tumour intrusion into the applicator tube were examined through Monte Carlo (MC) simulations and, for the first time, direct in-applicator dose measurements. Approach. QI measurements were performed every four weeks from mid-2022. Half-value layer (HVL) and depth-dose profile measurements in a plastic water low energy range phantom were conducted twice, with a two-year interval. Dose distributions for tumour intrusion scenarios (2.5–10 mm) were assessed using MC simulations and Gafchromic film measurements inside the applicator tube. Gross tumour volume (GTV) dose calculations (physical and EQD2) were performed for varying tumour thicknesses, intrusion depths, and diameters. Main results. All methods consistently demonstrated progressive beam hardening over time, with the HVL increasing from 0.77 mm Al to 0.93 mm Al. This spectral shift, attributed to x-ray tube ageing and radiation-induced material changes, was reversibly corrected after service replacement of the flattening filter, restoring the soft spectrum (HVL ≈ 0.69 mm Al). Tumour intrusion produced the strongest dosimetric effect, with surface dose increases up to 2.4-fold at 10 mm intrusion, exceeding MC predictions. GTV D90 decreased with tumour thickness but increased sharply with intrusion depth, whereas tumour diameter and surrounding medium had a negligible impact. Significance. This work highlights the importance of systematic beam quality follow-up in contact x-ray brachytherapy systems. Routine QI monitoring, together with well-defined beam-quality specifications and action limits, enables early detection of deviations, timely maintenance, and sustained compliance of the delivered beam quality in clinical practice. Tumour positioning relative to and protrusion into the applicator remains the dominant factor affecting dose distribution, underscoring the need for precise clinical setup and ongoing device characterisation to ensure clinical accuracy and patient safety.
- 17 April 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (8) , 085007
Assessing dosimetric uncertainties in Papillon+ contact x-ray brachytherapy for rectal cancer: impact of beam quality and tumour geometry
Objective. To investigate the evolution of beam quality in the Papillon+ contact x-ray therapy device and its dosimetric impact, a fast and straightforward beam quality index (QI) measurement method was proposed and validated. Additionally, the dosimetric consequences of tumour intrusion into the applicator tube were examined through Monte Carlo (MC) simulations and, for the first time, direct in-applicator dose measurements. Approach. QI measurements were performed every four weeks from mid-2022. Half-value layer (HVL) and depth-dose profile measurements in a plastic water low energy range phantom were conducted twice, with a two-year interval. Dose distributions for tumour intrusion scenarios (2.5–10 mm) were assessed using MC simulations and Gafchromic film measurements inside the applicator tube. Gross tumour volume (GTV) dose calculations (physical and EQD2) were performed for varying tumour thicknesses, intrusion depths, and diameters. Main results. All methods consistently demonstrated progressive beam hardening over time, with the HVL increasing from 0.77 mm Al to 0.93 mm Al. This spectral shift, attributed to x-ray tube ageing and radiation-induced material changes, was reversibly corrected after service replacement of the flattening filter, restoring the soft spectrum (HVL ≈ 0.69 mm Al). Tumour intrusion produced the strongest dosimetric effect, with surface dose increases up to 2.4-fold at 10 mm intrusion, exceeding MC predictions. GTV D90 decreased with tumour thickness but increased sharply with intrusion depth, whereas tumour diameter and surrounding medium had a negligible impact. Significance. This work highlights the importance of systematic beam quality follow-up in contact x-ray brachytherapy systems. Routine QI monitoring, together with well-defined beam-quality specifications and action limits, enables early detection of deviations, timely maintenance, and sustained compliance of the delivered beam quality in clinical practice. Tumour positioning relative to and protrusion into the applicator remains the dominant factor affecting dose distribution, underscoring the need for precise clinical setup and ongoing device characterisation to ensure clinical accuracy and patient safety.
- Open Access
- 13 March 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (5) , 055016
Evaluation of radiological properties and anisotropy with air channels analysis in 3D-printed flexible lung-mimicking materials for radiotherapy
Objective. Three-dimensional (3D) printing is increasingly used for radiotherapy quality assurance (QA) phantoms, yet, reproducing the structural heterogeneity and radiological properties of lung tissue remains challenging. This study evaluates thermoplastic polyurethane (TPU) for dynamic lung-mimicking phantoms, selected for its flexibility while preserving print-defined geometry, with a focus on radiological equivalence, directional anisotropy, and the detectability of sub-millimetre air channels. Approach. Eleven TPU materials with various colours and Shore hardness (63–82) were printed into gyroid-patterned inserts of varying infill densities. Effective atomic number ( Z eff ) and relative electron density (RED) were determined using dual-energy computed tomography (CT). Anisotropy and internal air channels were assessed in five orientations using micro-CT, clinical CT, and flat-panel detector (FPD) imaging, and compared to a voxelised digital model derived from G-code toolpaths. Main results . Measured Z eff ranged from 6.3 ± 0.6 to 11.1 ± 0.2, with pigment-driven variation up to 66% within identical material categories. Seven materials achieved lung mimicking Z eff (around 7.55). RED increased with infill and mimicked lung references (0.28–0.43) at moderate infill. The low-infill insert contained 0.7 mm air channels visible in all modalities. The high-infill insert contained 0.3 mm channels, resolved accurately by the micro-CT and FPD but not reliably resolved by clinical CT due to resolution limitations. The digital model indicated diagonal anisotropy, micro-CT and FPD indicated near-isotropy in low and high infill, while CT showed apparent anisotropy due to its resolution limitations. Significance . TPU-based gyroid phantoms are suitable lung-mimicking candidates for radiotherapy QA of imaging and dosimetry. Their periodic air-channels are reliably resolved by high-resolution imaging (micro-CT or FPD), but may be distorted by clinical CT, particularly in resolution-limited orientations, the digital model supports pre-print evaluation of these air-channels. Because undetected internal heterogeneities may affect dose calculation accuracy, high-resolution imaging when available, is preferred for assessing the internal structure of 3D-printed phantoms.
- 13 March 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (5) , 055016
Open AccessEvaluation of radiological properties and anisotropy with air channels analysis in 3D-printed flexible lung-mimicking materials for radiotherapy
Objective. Three-dimensional (3D) printing is increasingly used for radiotherapy quality assurance (QA) phantoms, yet, reproducing the structural heterogeneity and radiological properties of lung tissue remains challenging. This study evaluates thermoplastic polyurethane (TPU) for dynamic lung-mimicking phantoms, selected for its flexibility while preserving print-defined geometry, with a focus on radiological equivalence, directional anisotropy, and the detectability of sub-millimetre air channels. Approach. Eleven TPU materials with various colours and Shore hardness (63–82) were printed into gyroid-patterned inserts of varying infill densities. Effective atomic number ( Z eff ) and relative electron density (RED) were determined using dual-energy computed tomography (CT). Anisotropy and internal air channels were assessed in five orientations using micro-CT, clinical CT, and flat-panel detector (FPD) imaging, and compared to a voxelised digital model derived from G-code toolpaths. Main results . Measured Z eff ranged from 6.3 ± 0.6 to 11.1 ± 0.2, with pigment-driven variation up to 66% within identical material categories. Seven materials achieved lung mimicking Z eff (around 7.55). RED increased with infill and mimicked lung references (0.28–0.43) at moderate infill. The low-infill insert contained 0.7 mm air channels visible in all modalities. The high-infill insert contained 0.3 mm channels, resolved accurately by the micro-CT and FPD but not reliably resolved by clinical CT due to resolution limitations. The digital model indicated diagonal anisotropy, micro-CT and FPD indicated near-isotropy in low and high infill, while CT showed apparent anisotropy due to its resolution limitations. Significance . TPU-based gyroid phantoms are suitable lung-mimicking candidates for radiotherapy QA of imaging and dosimetry. Their periodic air-channels are reliably resolved by high-resolution imaging (micro-CT or FPD), but may be distorted by clinical CT, particularly in resolution-limited orientations, the digital model supports pre-print evaluation of these air-channels. Because undetected internal heterogeneities may affect dose calculation accuracy, high-resolution imaging when available, is preferred for assessing the internal structure of 3D-printed phantoms.
- Open Access
- 30 December 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (1) , 015019
Validation of Monte Carlo simulations with measurement data for fetal dose assessment in proton therapy for breast cancer
Objective . This study aims to validate a Monte Carlo model for fetal dose estimation in the complex secondary field of pencil beam scanning (PBS) proton therapy for breast cancer, one of the most common cancers occurring during pregnancy. Approach . A TOPAS/GEANT4 Monte Carlo simulation environment based on an IBA ProteusOne beam model was developed, reflecting the experimental setup of a breast irradiation using a pregnant anthropomorphic phantom. Experimental doses were acquired with thermoluminescent dosimeters for protons and gammas, and bubble detectors (BDs) for neutrons. Simulated doses were scored at the same positions using three hadronic physics models: BIC_HP, BIC_AllHP, and BERT_HP. Experimental doses were corrected for detector energy response using simulation-derived energy spectra. Main results . Agreement between simulation and measurement varied depending on hadronic model, scoring volume size, and correcting for BD energy response. Two physics models conservatively estimated fetal neutron doses within the combined measurement and simulation uncertainties, with BIC_AllHP showing the closest agreement. Combined proton and gamma doses were accurately reproduced for all models for inserts 2–6, but were underestimated for insert 1, likely due to dose gradients and modeling limitations near the treatment field. The total simulated fetal dose equivalent at the fundus height was 5.17 mSv. This value is substantially lower than doses reported for photon-based therapies, remains well below the 100 mSv threshold for deterministic effects, and is within range of the public 1 mSv dose limit. Significance . The results demonstrate that, within the tested experimental framework, the TOPAS/GEANT4 Monte Carlo model is suitable for fetal dose estimation in PBS proton therapy for breast cancer. In this setting, calculated fetal doses were substantially lower than those reported for photon-based radiotherapy. The validated framework provides a practical basis for treatment planning optimization and risk assessment and can be extended to other clinical scenarios following similar validation.
- 30 December 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (1) , 015019
Open AccessValidation of Monte Carlo simulations with measurement data for fetal dose assessment in proton therapy for breast cancer
Objective . This study aims to validate a Monte Carlo model for fetal dose estimation in the complex secondary field of pencil beam scanning (PBS) proton therapy for breast cancer, one of the most common cancers occurring during pregnancy. Approach . A TOPAS/GEANT4 Monte Carlo simulation environment based on an IBA ProteusOne beam model was developed, reflecting the experimental setup of a breast irradiation using a pregnant anthropomorphic phantom. Experimental doses were acquired with thermoluminescent dosimeters for protons and gammas, and bubble detectors (BDs) for neutrons. Simulated doses were scored at the same positions using three hadronic physics models: BIC_HP, BIC_AllHP, and BERT_HP. Experimental doses were corrected for detector energy response using simulation-derived energy spectra. Main results . Agreement between simulation and measurement varied depending on hadronic model, scoring volume size, and correcting for BD energy response. Two physics models conservatively estimated fetal neutron doses within the combined measurement and simulation uncertainties, with BIC_AllHP showing the closest agreement. Combined proton and gamma doses were accurately reproduced for all models for inserts 2–6, but were underestimated for insert 1, likely due to dose gradients and modeling limitations near the treatment field. The total simulated fetal dose equivalent at the fundus height was 5.17 mSv. This value is substantially lower than doses reported for photon-based therapies, remains well below the 100 mSv threshold for deterministic effects, and is within range of the public 1 mSv dose limit. Significance . The results demonstrate that, within the tested experimental framework, the TOPAS/GEANT4 Monte Carlo model is suitable for fetal dose estimation in PBS proton therapy for breast cancer. In this setting, calculated fetal doses were substantially lower than those reported for photon-based radiotherapy. The validated framework provides a practical basis for treatment planning optimization and risk assessment and can be extended to other clinical scenarios following similar validation.
- Open Access
- 23 April 2025
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 53, 100963
Microscopic intramural spread in patients with rectal cancer after neoadjuvant chemoradiation
- 23 April 2025
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 53, 100963
Open AccessMicroscopic intramural spread in patients with rectal cancer after neoadjuvant chemoradiation
- 1 July 2020
- Published by Elsevier in Brachytherapy
- Vol. 19 (4) , 544-553
Advanced design, simulation, and dosimetry of a novel rectal applicator for contact brachytherapy with a conventional HDR 192Ir source
- 1 July 2020
- Published by Elsevier in Brachytherapy
- Vol. 19 (4) , 544-553
Advanced design, simulation, and dosimetry of a novel rectal applicator for contact brachytherapy with a conventional HDR 192Ir source
- 1 March 2020
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 144, 37-45
Microscopic intramural extension of rectal cancer after neoadjuvant chemoradiation: A meta-analysis based on individual patient data
- 1 March 2020
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 144, 37-45
Microscopic intramural extension of rectal cancer after neoadjuvant chemoradiation: A meta-analysis based on individual patient data
- 1 November 2019
- Published by Elsevier in Brachytherapy
- Vol. 18 (6) , 852-862
Mechanical evaluation of the Bravos afterloader system for HDR brachytherapy
- 1 November 2019
- Published by Elsevier in Brachytherapy
- Vol. 18 (6) , 852-862
Mechanical evaluation of the Bravos afterloader system for HDR brachytherapy
- 2 November 2018
- Published by Elsevier in Brachytherapy
- Vol. 18 (1) , 71-86.e5
A systematic review comparing radiation toxicity after various endorectal techniques
- 2 November 2018
- Published by Elsevier in Brachytherapy
- Vol. 18 (1) , 71-86.e5
A systematic review comparing radiation toxicity after various endorectal techniques
- 1 November 2018
- Published by Elsevier in Brachytherapy
- Vol. 17 (6) , 1037-1044
A novel rectal applicator for contact radiotherapy with HDR 192Ir sources
- 1 November 2018
- Published by Elsevier in Brachytherapy
- Vol. 17 (6) , 1037-1044
A novel rectal applicator for contact radiotherapy with HDR 192Ir sources